Sanofi (SNY) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SNY Annual Balance Sheets →
This page allows investors to track Sanofi's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents8,575.84
Other Short-term Investments529.29
Cash & Short-term Investments9,104.00
Accounts receivable9,419.20
Notes Receivable, Current4,887.68
Other Current Assets11,338.88
Total Current Assets34,666.24
Equipment/Property/Plant Net11,258.24
Goodwill net46,256.00
Deferred Tax Assets9,640.96
Other Assets, Noncurrent40,200.16
Total Assets142,021.60
Liabilities
Longterm Borrowings15,957.76
Other Liabilities, Current15,788.64
Total Current Liabilities31,746.40
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI1,865.92
Total Liabilities61,706.40
Stockholders' Equity
Other Equity80,272.64
Common Stockholder's Equity80,272.64
Total Stockholder's Equity80,315.20
Liabilities & Stockholder's Equity142,021.60
4 historic quarters locked

Sign in to unlock the full Sanofi balance sheet history.

About Sanofi Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 17, 2026
  • Source: sny-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-008403

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.